医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

PathCentral Launches Digital Pathology Network, The First Comprehensive Online Information Exchange Open to the Global Pathology Community

2013年03月04日 PM08:25
このエントリーをはてなブックマークに追加


 

IRVINE, Calif.

USCAP 2013, Booth #1002 – PathCentral (www.pathcentral.net), a technology-enabled company dedicated to the success of the pathology community, today unveiled the PathCentral Pathology Network at www.pathcentralpro.net — the specialty’s most comprehensive online information exchange and digital consultation forum. The company made the announcement at the 102nd USCAP Annual Meeting, in session through March 8 in Baltimore.

The PathCentral Pathology Network enables physicians to upload case files using digital images for pathologists to review and render critical consulting diagnoses on both a global and a domestic real-time basis. In terms of scanning technology and imaging software, the Network is agnostic and designed to be non-exclusive – that is, open to all users regardless of location or consulting institution. The PathCentral Pathology Network seeks to connect the world’s pathologists, incorporating tools from social media, making it an ideal forum for pathologists to send and perform consults, create connections, post information, share cases, ask questions, and expand professional relationships.

PathCentral has long been a pioneer in cloud-hosted solutions for the pathology community, through its Anatomic Pathology Laboratory Information Systems (APLIS). The core IT infrastructure in the APLIS is the backbone of almost every reference laboratory that offers remote review of cases via “tech only” testing. This technology, forged over the last 12 years, fueled development of the PathCentral Pathology Network. Today, it represents the industry’s first open, cloud-based platform, harnessing all the technologies of social media, digital imaging and laboratory information system functionality under one virtual roof.

“We envision that the PathCentral Pathology Network will help pathologists in various facets of their practice by freeing them up from their physical location and providing a venue to consult, collaborate and connect to anywhere in the world,” said Jaye Connolly, Chief Executive Officer, PathCentral. “The Network not only enables us to electronically connect a broad base of users, it helps address the global shortage of highly qualified pathology consultants by bringing their expertise to all corners of the globe. As a truly open network, it will uniquely encourage participation and feedback from everyone who accesses it.”

In January, China-based Kindstar Globalgene Technology, Inc. became the first international organization to sign on to the Network as a sender and a user. Through its participation, Kindstar will be able to access U.S. pathologists and facilitate pathology consultations for more than 3,300 hospitals throughout China. Kindstar and its clients will gain access to hundreds of American pathologists at leading U.S. medical institutions, including many of the top 50 cancer centers, delivering patient diagnoses to physicians in China via the cloud.

About PathCentral

Through its comprehensive suite of products and services, PathCentral provides independent community-based pathologists with the tools they need to increase revenues, improve operating efficiencies, ensure patient safety, and become highly competitive in their local markets. With its blend of leading edge IT cloud computing technology and global connectivity, PathCentral intends to enable pathologists around the world to grow, thrive and more effectively meet the demands of 21st Century diagnostic medicine. For more information, please visit www.pathcentral.net.

CONTACT

Edge Communications, Inc.
Ken Greenberg, 323-469-3397
ken@edgecommunicationsinc.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent